Inhibitory effect of metformin on TNF-α expression in hepatic tissue of OLETF rats
Wei Wang
Abstract
Wei Wang
Abstract
Objective To investigate the TNF-α expression in hepatic tissue of Otsuka Long-Evans Tokushima Fatty(OLETF) rats(an insulin resistance model) with abnormalities of glucose-lipid metabolism and effect of metformin on TNF-α expression.Methods OLETF rats were randomly assigned to two groups(OLETF and OLETF/M).The OLETF/M group was treated with metformin [100 mg/(kg·d)],the OLETF group and age-matched LETO(nondiabetic Long-Evans Tokushima Otsuka rats) group were fed with placebo.Twenty-two weeks after treatment,we analyzed hepatic triglyceride level and measured expression of TNF-α by western-blot(protein) and quantitative RT-PCR(mRNA).Results Twenty-two weeks after treatment,the level of fasting glucose,insulin,triglyceride,free fatty acids(FFA) and hepatic triglyceride increased significantly in OLETF group as compared with LETO group.Western-blot method showed upregulated expression of TNF-α protein in OLETF group(1.57-fold vs LETO group,P0.05).At the mRNA level,expression of TNF-α was also significantly elevated in OLETF group(1.67-fold vs LETO group,P0.05).Metformin reduced the level of fasting glucose,insulin,FFA and hepatic triglyceride significantly in OLETF/M group.After treatment of metformin,the expressions of TNF-α protein andmRNA in hepatic tissue downregulated(protein: 59%,P0.05 and mRNA: 45%,P0.05)in OLETF/M group.Conclusion The therapeutic effects of metformin on insulin resistance and fatty liver disease are associated with significant suppression of TNF-α expression in hepatic tissue.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the TNF-α expression in hepatic tissue of Otsuka Long-Evans Tokushima Fatty(OLETF) rats(an insulin resistance model) with abnormalities of glucose-lipid metabolism and effect of metformin on TNF-α expression.Methods OLETF rats were randomly assigned to two groups(OLETF and OLETF/M).The OLETF/M group was treated with metformin [100 mg/(kg·d)],the OLETF group and age-matched LETO(nondiabetic Long-Evans Tokushima Otsuka rats) group were fed with placebo.Twenty-two weeks after treatment,we analyzed hepatic triglyceride level and measured expression of TNF-α by western-blot(protein) and quantitative RT-PCR(mRNA).Results Twenty-two weeks after treatment,the level of fasting glucose,insulin,triglyceride,free fatty acids(FFA) and hepatic triglyceride increased significantly in OLETF group as compared with LETO group.Western-blot method showed upregulated expression of TNF-α protein in OLETF group(1.57-fold vs LETO group,P0.05).At the mRNA level,expression of TNF-α was also significantly elevated in OLETF group(1.67-fold vs LETO group,P0.05).Metformin reduced the level of fasting glucose,insulin,FFA and hepatic triglyceride significantly in OLETF/M group.After treatment of metformin,the expressions of TNF-α protein andmRNA in hepatic tissue downregulated(protein: 59%,P0.05 and mRNA: 45%,P0.05)in OLETF/M group.Conclusion The therapeutic effects of metformin on insulin resistance and fatty liver disease are associated with significant suppression of TNF-α expression in hepatic tissue.
Key concepts: Internal medicine, Endocrinology, Metformin, Insulin resistance, Triglyceride, Medicine, Insulin, Western blot